@FierceBiotech: Florida city carves out 1-square-mile biotech hub. Article | Follow @FierceBiotech
@JohnCFierce: Biotech Deal Activity Takes a Breather. Report. It's been too quiet on that front. I hate dull. | Follow @JohnCFierce
> Juventas has begun an early-stage trial of its experimental stem cell therapy, which is designed to repair damaged hearts. Story
> AcelRx Pharmaceuticals named Richard King as president and chief executive officer. King had been president and general manager of Tercica, which was acquired by Ipsen SA in 2008. AcelRx release
> Valeant Pharmaceuticals will offer $350 million in unsecured notes. Valeant release
> Cephalon completed its $250 million acquisition of Ception Therapeutics late Monday. Story
And Finally... An estimated 10 million American adults have all the symptoms of ADHD, and fewer than a quarter of them know. Story